发明名称 SULFONE AMIDE DERIVATIVE AS BCL-2-SELECTIVE APOPTOSIS INDUCING AGENT FOR TREATMENT OF CANCER AND IMMUNE DISEASE
摘要 PROBLEM TO BE SOLVED: To provide a compound which inhibits activity of anti-apoptosis BcI-2 or BcI-xL protein, and a composition containing the compound for treatment of cancer.SOLUTION: There are provided a compound represented by a formula (I) which inhibits activity of anti-apoptosis BcI-2 or BcI-xL protein, where Ais N and the like, B, Dand Eare an alkoxy group and the like, Yis H and the like, and Zis a substituted phenyl group and the like, and a composition containing the compound for treatment of bladder cancer, brain tumor, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular carcinoma, lymphoblast leukemia, follicular lymphoma, T cell- or B cell-originated lymphatic malignancy, melanoma, myelocytic leukemia, myeloma, oral cavity cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer, or spleen cancer.
申请公布号 JP2015129134(A) 申请公布日期 2015.07.16
申请号 JP20150005014 申请日期 2015.01.14
申请人 ABBVIE INC 发明人 MILAN BRUNCKO;DING HONG;GEORGE A DOHERTY;STEVEN W ELMORE;LISA HASVOLD;LAURA HEXAMER;AARON R KUNZER;ROBERT A MANTEI;WILLIAM J MCCLELLAN;CHANG H PARK;PARK CHEOL-MIN;ANDREW M PETROS;SONG XIAOHONG;ANDREW J SOUERS;GERARD M SULLIVAN;TAO ZHI-FU;GARY T WANG;LE WANG;XILU WANG;WENDT MICHAEL D
分类号 C07D205/08;A61K31/496;A61K31/501;A61K31/5377;A61K31/541;A61P35/00;A61P35/02;C07D207/09;C07D209/08;C07D209/52;C07D211/26;C07D211/58;C07D213/64;C07D213/65;C07D213/68;C07D215/20;C07D217/02;C07D231/56;C07D235/06;C07D237/14;C07D249/06;C07D295/10;C07D295/12;C07D309/04;C07D333/20;C07D401/12;C07D401/14;C07D403/12;C07D405/04;C07D405/12;C07D405/14;C07D407/12;C07D409/12;C07D413/14;C07D417/14;C07D451/04 主分类号 C07D205/08
代理机构 代理人
主权项
地址